Literature DB >> 16901898

The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.

Leonid A Sitailo1, Shalini S Tibudan, Mitchell F Denning.   

Abstract

Proteolytic cleavage and subsequent activation of protein kinase C (PKC) delta is required for apoptosis induced by a variety of genotoxic agent, including UV radiation. In addition, overexpression of the constitutively active PKCdelta catalytic fragment (PKCdelta-cat) is sufficient to trigger Bax activation, cytochrome c release, and apoptosis. While PKCdelta is a key apoptotic effector, the downstream target(s) responsible for the mitochondrial apoptotic cascade are not known. We found that expression of the active PKCdelta-cat in HaCaT cells triggers a reduction in the anti-apoptotic protein Mcl-1, similar to UV radiation. The down-regulation of Mcl-1 induced by PKCdelta-cat was not at the mRNA level but was due to decreased protein half-life. Overexpression of Mcl-1 protected HaCaT cells from both UV and PKCdelta-cat-induced apoptosis and blocked the release of cytochrome c from the mitochondria, indicating that Mcl-1 down-regulation was required for apoptosis signaling. Indeed, down-regulation of Mcl-1 with siRNA slightly increased the basal apoptotic rate of HaCaT cells and dramatically sensitized them to UV or PKCdelta-cat-induced apoptosis. HaCaT cells with down-regulated Mcl-1 had higher activated Bax protein, as measured by Bax cross-linking, indicating that Mcl-1 down-regulation is sufficient for Bax activation. Finally, recombinant PKCdelta could phosphorylate Mcl-1 in vitro, identifying Mcl-1 as a direct target for PKCdelta. Overall our results identify Mcl-1 as an important target for PKCdelta-cat that can mediate its pro-apoptotic effects on mitochondria to amplify the apoptotic signaling induced by a wide range of apoptotic stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901898      PMCID: PMC2205529          DOI: 10.1074/jbc.M607351200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Direct repression of the Mcl-1 promoter by E2F1.

Authors:  Rhonda Croxton; Yihong Ma; Lanxi Song; Eric B Haura; W Douglas Cress
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

2.  Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.

Authors:  Rhonda Croxton; Yihong Ma; W Douglas Cress
Journal:  Oncogene       Date:  2002-02-28       Impact factor: 9.867

3.  PKCdelta is required for mitochondrial-dependent apoptosis in salivary epithelial cells.

Authors:  A A Matassa; L Carpenter; T J Biden; M J Humphries; M E Reyland
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

4.  MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.

Authors:  J Bae; C P Leo; S Y Hsu; A J Hsueh
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

5.  Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C.

Authors:  M F Denning; Y Wang; S Tibudan; S Alkan; B J Nickoloff; J-Z Qin
Journal:  Cell Death Differ       Date:  2002-01       Impact factor: 15.828

6.  Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta.

Authors:  S C Frasch; P M Henson; J M Kailey; D A Richter; M S Janes; V A Fadok; D L Bratton
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

7.  Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.

Authors:  A M Domina; J H Smith; R W Craig
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

8.  Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen.

Authors:  K Fujise; D Zhang; J Liu; E T Yeh
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

9.  Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.

Authors:  D Grossman; P J Kim; O P Blanc-Brude; D E Brash; S Tognin; P C Marchisio; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation.

Authors:  Mohamed Rahmani; Eric Maynard Davis; Cheryl Bauer; Paul Dent; Steven Grant
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

View more
  19 in total

1.  Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons.

Authors:  M M Magiera; S Mora; B Mojsa; I Robbins; I Lassot; S Desagher
Journal:  Cell Death Differ       Date:  2012-09-14       Impact factor: 15.828

2.  PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents.

Authors:  Gautam Adhikary; Yap Ching Chew; E Albert Reece; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

3.  Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Authors:  Hercules Apostolatos; André Apostolatos; Timothy Vickers; James E Watson; Shijie Song; Fernando Vale; Denise R Cooper; Juan Sanchez-Ramos; Niketa A Patel
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

Review 4.  Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

Authors:  Mary E Reyland; David N M Jones
Journal:  Pharmacol Ther       Date:  2016-05-11       Impact factor: 12.310

5.  Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells.

Authors:  Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  Exp Cell Res       Date:  2009-11-10       Impact factor: 3.905

6.  Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.

Authors:  Meng Zhao; Xu-Fang Duan; Xu-Yun Zhao; Bo Zhang; Ying Lu; Wei Liu; Jin-Ke Cheng; Guo-Qiang Chen
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

7.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

Authors:  Vivian R Ruvolo; Kul B Karanjeet; Todd F Schuster; Rhoderick Brown; Yibin Deng; Edward Hinchcliffe; Peter P Ruvolo
Journal:  J Signal Transduct       Date:  2010-01-01

9.  Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study.

Authors:  Vipin Yadav; Nicole C Yanez; Sarah E Fenton; Mitchell F Denning
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

10.  Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.

Authors:  Xia Wang; Wenshu Chen; Weihua Zeng; Lang Bai; Yohannes Tesfaigzi; Steven A Belinsky; Yong Lin
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.